Volume 11, Issue 6, Pages (June 2004)

Slides:



Advertisements
Similar presentations
Volume 13, Issue 10, Pages (October 2006)
Advertisements

Volume 11, Issue 8, Pages (August 2003)
Volume 10, Issue 8, Pages (August 2002)
Structure of the Rho Family GTP-Binding Protein Cdc42 in Complex with the Multifunctional Regulator RhoGDI  Gregory R. Hoffman, Nicolas Nassar, Richard.
Volume 10, Issue 5, Pages (November 2002)
Indi Trehan, Federica Morandi, Larry C Blaszczak, Brian K Shoichet 
Structural Basis for the Highly Selective Inhibition of MMP-13
Volume 10, Issue 8, Pages (August 2002)
Structure and Protein Design of a Human Platelet Function Inhibitor
Volume 20, Issue 6, Pages (June 2013)
Volume 11, Issue 10, Pages (October 2004)
Volume 3, Issue 3, Pages (March 1999)
Volume 24, Issue 5, Pages (December 2006)
Volume 21, Issue 5, Pages (May 2013)
Volume 15, Issue 8, Pages (August 2007)
Volume 124, Issue 2, Pages (January 2006)
Volume 115, Issue 2, Pages (October 2003)
Volume 11, Issue 8, Pages (August 2003)
Volume 85, Issue 7, Pages (June 1996)
Volume 16, Issue 10, Pages (October 2008)
Volume 10, Issue 12, Pages (December 2002)
Volume 8, Issue 12, Pages (December 2001)
Volume 14, Issue 5, Pages (May 2007)
Xiao Tao, Zhiru Yang, Liang Tong  Structure 
Volume 8, Issue 3, Pages (March 2000)
Volume 20, Issue 5, Pages (May 2012)
Volume 13, Issue 10, Pages (October 2006)
Volume 2, Issue 1, Pages (July 1998)
Crystal Structure of ARF1•Sec7 Complexed with Brefeldin A and Its Implications for the Guanine Nucleotide Exchange Mechanism  Elena Mossessova, Richard.
Volume 15, Issue 10, Pages (October 2008)
Volume 4, Issue 5, Pages (November 1999)
Volume 17, Issue 3, Pages (March 2009)
Volume 3, Issue 2, Pages (February 1995)
Moosa Mohammadi, Joseph Schlessinger, Stevan R Hubbard  Cell 
Volume 9, Issue 1, Pages (January 2002)
Volume 14, Issue 5, Pages (May 2006)
Volume 95, Issue 7, Pages (December 1998)
Volume 19, Issue 9, Pages (September 2011)
Alison Burgess Hickman, M.A.A. Namboodiri, David C. Klein, Fred Dyda 
Volume 21, Issue 6, Pages (June 2014)
Volume 3, Issue 5, Pages (May 1999)
Volume 6, Issue 6, Pages (December 2000)
Structural Basis for the Highly Selective Inhibition of MMP-13
Transformation of MutL by ATP Binding and Hydrolysis
Volume 15, Issue 3, Pages (March 2007)
Structure of the Rho Family GTP-Binding Protein Cdc42 in Complex with the Multifunctional Regulator RhoGDI  Gregory R. Hoffman, Nicolas Nassar, Richard.
Volume 7, Issue 7, Pages (July 2000)
Volume 13, Issue 11, Pages (November 2006)
Volume 14, Issue 12, Pages (December 2006)
Crystal Structure of the N-Terminal Domain of Sialoadhesin in Complex with 3′ Sialyllactose at 1.85 Å Resolution  A.P. May, R.C. Robinson, M. Vinson,
Structural Insight into AMPK Regulation: ADP Comes into Play
Michael A. McDonough, Christopher J. Schofield  Chemistry & Biology 
Structural Basis of Swinholide A Binding to Actin
Crystal Structure of the Carboxyltransferase Domain of Acetyl-Coenzyme A Carboxylase in Complex with CP   Hailong Zhang, Benjamin Tweel, Jiang Li,
Alec E. Hodel, Paul D. Gershon, Florante A. Quiocho  Molecular Cell 
Ramon Hurtado-Guerrero, Daan M.F. van Aalten  Chemistry & Biology 
Molecular Similarity Analysis Uncovers Heterogeneous Structure-Activity Relationships and Variable Activity Landscapes  Lisa Peltason, Jürgen Bajorath 
The Structure of JNK3 in Complex with Small Molecule Inhibitors
Volume 20, Issue 1, Pages (January 2012)
Pingwei Li, Gerry McDermott, Roland K. Strong  Immunity 
Volume 10, Issue 4, Pages (April 2003)
Volume 15, Issue 6, Pages (June 2008)
Volume 127, Issue 7, Pages (December 2006)
Volume 9, Issue 8, Pages (August 2002)
The Structure of T. aquaticus DNA Polymerase III Is Distinct from Eukaryotic Replicative DNA Polymerases  Scott Bailey, Richard A. Wing, Thomas A. Steitz 
Volume 9, Issue 11, Pages (November 2002)
Volume 19, Issue 2, Pages (February 2012)
Volume 16, Issue 6, Pages (December 2004)
Volume 21, Issue 6, Pages (June 2013)
Volume 20, Issue 5, Pages (May 2012)
Presentation transcript:

Volume 11, Issue 6, Pages 775-785 (June 2004) Structure-Activity Relationships in Purine-Based Inhibitor Binding to HSP90 Isoforms  Lisa Wright, Xavier Barril, Brian Dymock, Louisa Sheridan, Allan Surgenor, Mandy Beswick, Martin Drysdale, Adam Collier, Andy Massey, Nick Davies, Alex Fink, Christophe Fromont, Wynne Aherne, Kathy Boxall, Swee Sharp, Paul Workman, Roderick E Hubbard  Chemistry & Biology  Volume 11, Issue 6, Pages 775-785 (June 2004) DOI: 10.1016/j.chembiol.2004.03.033

Figure 1 Structures of Nt-HSP90 Isoforms (A) Comparison of the structure of some apo-Nt-HSP90 proteins. The proteins are overlaid on all main chain atoms except for residues 104–111, which are colored in yellow for the tetragonal form of yeast HSP90 (PDB ID code 1AH6), red for orthorhombic form of yeast HSP90 (1AH8), green for human HSP90α (1YES), and purple for the apo-Nt-HSP90α structure reported here. This figure (and Figures 4 and 6) was produced using QUANTA (Accelrys, San Diego). (B) Comparison of apo (yellow) and PU3 bound (light blue) Nt-HSP90α highlighting the secondary structure (wider ribbons) and PU3 (in green stick). This figure (and [C] and Figure 3) was produced using ViewerPro (Accelrys, San Diego). (C) The structure of human Nt-HSP90β with PU3 bound (green stick). Amino acid differences between HSP90α and HSP90β are shown in yellow. Chemistry & Biology 2004 11, 775-785DOI: (10.1016/j.chembiol.2004.03.033)

Figure 2 PU3 Binding to HSP90 Schematic of interactions between PU3 and the binding site of Nt-HSP90α (figure produced using Ligplot, [32]). Chemistry & Biology 2004 11, 775-785DOI: (10.1016/j.chembiol.2004.03.033)

Figure 3 Binding of Ligands to Nt-HSP90α Key protein residues and water molecules shown for ADP (from PDB ID code 1BYQ, human), PU3 (this paper), geldanamycin (1YET, human), and radicicol (1BGQ, yeast). In addition, the PU3 panel includes an Fo-Fc electron density map contoured at 2.8 σ, calculated for the final refined structure with PU3 omitted. Carbon atoms for the protein are in dark gray and for ligand in light yellow. Oxygen atoms are red, nitrogen blue, sulfur yellow, and phosphorus orange. Water molecules are shown as small red spheres. Note that the equivalent residue to Leu 107 in human HSP90 is Asn in yeast. Chemistry & Biology 2004 11, 775-785DOI: (10.1016/j.chembiol.2004.03.033)

Figure 4 Purine Analogs and Enzyme Inhibition Data Chemistry & Biology 2004 11, 775-785DOI: (10.1016/j.chembiol.2004.03.033)

Figure 5 PU3 Ligands Elicit HSP90 Molecular Signature HCT116 cells were exposed to compounds 1, 8, and 11 at concentrations of 100 μM for 1 (2×GI50) and 17 μM for 8 and 16.5 μM for 11 (5×GI50) as described in the main text. Cell lysates obtained after 8, 16, 24, 48, 72, or 96 hr incubation were subjected to Western blot determination of HSP70, Raf-1, CDK4, and ErbB2. 17AAG is included as a positive compound control, and protein loading was established by GAPDH determination. Chemistry & Biology 2004 11, 775-785DOI: (10.1016/j.chembiol.2004.03.033)

Figure 6 Comparison of PU3 Ligands (A) Stereo figure showing the structure of four compounds overlaid together with selected amino acids (Trp 162, Met 98, Leu 107, Val 150, Phe 138, and Tyr 139) for a representative protein structure (with compound 2 bound). Nitrogens are blue, oxygens are red, and sulphurs are yellow. For the protein, carbons are green, with the carbons of different compounds colored as follows: purple is 1, yellow is 4, and green are 2 and 3. A key water molecule is shown as a sphere, absent in the 3 structure. (B) The structure of the 12 featured PU3 analogs bound to Nt-HSP90α, overlaid on the purine ring. Nitrogens are blue, oxygens are red, and fluorine or chlorine are light green. The carbons of the trimethoxy benzene-containing compounds (1, 6, 7, and 8) are in purple, the carbons of the OCH2O bridged compounds (4 and 12) are yellow, and the carbons of the other compounds are pale green. Chemistry & Biology 2004 11, 775-785DOI: (10.1016/j.chembiol.2004.03.033)